Gabrielle Sulzberger - Dec 31, 2023 Form 5 Insider Report for Cerevel Therapeutics Holdings, Inc. (CERE)

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Stock symbol
CERE
Transactions as of
Dec 31, 2023
Transactions value $
$0
Form type
5
Date filed
2/13/2024, 04:16 PM
Previous filing
Dec 19, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Gift $0 +562 +1.17% $0.00 48.4K Aug 29, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.